Rockwell Medical Q2 EPS $(0.18) Misses $(0.12) Estimate, Sales $18.08M Inline
Portfolio Pulse from Benzinga Newsdesk
Rockwell Medical (NASDAQ:RMTI) reported Q2 losses of $(0.18) per share, missing the analyst consensus estimate of $(0.12) by 50 percent. This is a 67.86 percent increase over losses from the same period last year. The company's quarterly sales of $18.08 million met the analyst consensus estimate, marking a 3.22 percent decrease from the same period last year.
August 14, 2023 | 10:01 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Rockwell Medical's Q2 earnings missed analyst estimates, with losses per share increasing by 67.86% YoY. Sales met estimates but decreased by 3.22% YoY.
Rockwell Medical's Q2 earnings missed analyst estimates, which is likely to negatively impact investor sentiment and potentially the stock price. The YoY increase in losses per share and decrease in sales further contribute to this negative outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100